1 / 10

Deep vein thrombosis

Deep vein thrombosis. Color duplex scan of DVT. Venogram shows DVT. Patient with suspect symptomatic Acute lower extremity DVT. negative. Venous duplex scan. Low clinical probability. observe. High clinical probability. positive. negative.

Download Presentation

Deep vein thrombosis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Deep vein thrombosis

  2. Color duplex scan of DVT

  3. Venogram shows DVT

  4. Patient with suspect symptomatic Acute lower extremity DVT negative Venous duplex scan Low clinical probability observe High clinical probability positive negative Evaluate coagulogram /thrombophilia/ malignancy Repeat scan / Venography IVC filter Anticoagulant therapy contraindication yes No pregnancy LMWH OPD LMWH + warfarin hospitalisation UFH Compression treatment

  5. Thrombophilia screeningFactor V leiden, Prot C/S deficiency Antithrombin III deficiency • Idiopathic DVT < 50 years • Family history of DVT • Thrombosis in an unusual site • Recurrent DVT

  6. Recommendation for duration of warfarin • 3-6 months first DVT with reversible risk factors • At least 6 months for first idiopathic DVT • 12 months to lifelong for recurrent DVT or first DVT with irreversible risk factors malignancy or thrombophilic state

  7. Diagram 6

  8. Phlegmasia cerulea dolensVenous gangrene

  9. Catheter directed-thrombolysis • Consider in: Acute< 10 days iliofemoral DVT. • Long-term benefit in preventing post-phebitic syndrome is unknown.

More Related